Chin Jia-Jin, Lee Hui-Mei, Lee Shuet-Yi, Lee Yin-Ying, Chew Choy-Hoong
Department of Allied Health Sciences, Faculty of Science, Universiti Tunku Abdul Rahman (UTAR), 31900 Kampar, Perak, Malaysia.
Trop Life Sci Res. 2024 Jul;35(2):211-225. doi: 10.21315/tlsr2024.35.2.10. Epub 2024 Jul 31.
The rapid emergence of multidrug-resistant (MDR) uropathogenic (UPEC) strains pose a critical challenge in urinary tract infection (UTI) treatments. However, little work elucidated the resistance mechanisms of the MDR UPEC clinical strains in Malaysia. Therefore, this study aimed to determine the antimicrobial susceptibility profiles and the prevalence of antimicrobial resistance genes among the UPEC strains. Polymerase chain reactions were conducted to detect the presence of 6 antimicrobial resistance genes among 60 UPEC strains. Meanwhile, the antimicrobial resistance profiles against 9 antimicrobials were examined through the Kirby-Bauer disk diffusion method. In this study, the MDR isolates accounted for 40.0% (24/60), with the highest prevalence of resistance towards ampicillin (43/60; 71.7%), followed by tetracycline (31/60; 51.7%), nalidixic acid (30/60; 50.0%), co-trimoxazole (20/60, 33.3%), ciprofloxacin (19/60, 31.7%), levofloxacin (16/60, 21.6%) and chloramphenicol (10/60, 16.7%). In contrast, low resistance rates were observed among minocycline (1/60; 1.7%) and imipenem (0/60; 0.0%). was the most prevalent gene (36/60; 60.0%), followed by (27/60; 45.0%), (25/60; 41.7%), (13/60; 21.7%) and (8/60; 13.3%). Surprisingly, was not detected among the UPEC isolates. The MDR, ampicillin and tetracycline-resistant isolates were significantly associated with a higher prevalence of , , and . In contrast, displayed no significant relationship with any of the antimicrobials tested. The patient's age and gender were not the risk factors for the carriage of the resistance genes. Our findings identified the common resistance genes carried by the antimicrobial resistant UPEC isolates and provide valuable insights into developing the best antibiotic prescription regime to treat UTIs in our local scene.
多重耐药性尿路致病性大肠杆菌(UPEC)菌株的迅速出现给尿路感染(UTI)治疗带来了严峻挑战。然而,在马来西亚,针对多重耐药性UPEC临床菌株耐药机制的研究工作很少。因此,本研究旨在确定UPEC菌株的抗菌药物敏感性概况以及抗菌耐药基因的流行情况。采用聚合酶链反应检测60株UPEC菌株中6种抗菌耐药基因的存在情况。同时,通过 Kirby-Bauer 纸片扩散法检测这些菌株对9种抗菌药物的耐药情况。在本研究中,多重耐药菌株占40.0%(24/60),对氨苄西林的耐药率最高(43/60;71.7%),其次是四环素(31/60;51.7%)、萘啶酸(30/60;50.0%)、复方新诺明(20/60,33.3%)、环丙沙星(19/60,31.7%)、左氧氟沙星(16/60,21.6%)和氯霉素(10/60,16.7%)。相比之下,米诺环素(1/60;1.7%)和亚胺培南(0/60;0.0%)的耐药率较低。[此处原文缺失基因名称]是最常见的基因(36/60;60.0%),其次是[此处原文缺失基因名称](27/60;45.0%)、[此处原文缺失基因名称](25/60;41.7%)、[此处原文缺失基因名称](13/60;21.7%)和[此处原文缺失基因名称](8/60;13.3%)。令人惊讶的是,在UPEC分离株中未检测到[此处原文缺失基因名称]。多重耐药、对氨苄西林和四环素耐药的分离株与[此处原文缺失基因名称]、[此处原文缺失基因名称]、[此处原文缺失基因名称]和[此处原文缺失基因名称]的较高流行率显著相关。相比之下,[此处原文缺失基因名称]与所测试的任何抗菌药物均无显著关系。患者的年龄和性别不是携带耐药基因的风险因素。我们的研究结果确定了抗菌耐药性UPEC分离株携带的常见耐药基因,并为制定最佳抗生素处方方案以治疗我们当地的尿路感染提供了有价值的见解。